期刊文献+

丙戊酸盐治疗痴呆精神行为症状有效性和安全性的Meta分析 被引量:3

Efficacy and safety ofvalproatein treatment of behavioral and psychological symptoms of dementia (BPSD): Meta-analysis
原文传递
导出
摘要 目的:系统评价丙戊酸盐治疗痴呆精神行为症状的有效性和安全性。方法:计算机检索The Cochrane Library(2018年12期)、EMbase、PubMed、CNKI、CBM、VIP和WanFang Data数据库,搜集丙戊酸盐治疗痴呆精神行为症状的随机对照试验,检索时限均为建库至2018年12月。由两位研究者独立筛选文献、提取资料和评价纳入研究的偏倚风险后,采用RevMan5.3软件进行meta分析。结果:共纳入14个研究,累计患者1 043例,其中试验组501例,对照组542例。Meta分析结果显示:与对照组相比,丙戊酸盐组可显著提高NPI总评分[SMD=0.46,95%CI(0.21,0.72),P=0.0003],降低MMSE评分[SMD=-0.36,95%CI(-0.58,-0.15),P=0.001],差异具有显著性,同时不明显增加不良反应发生风险。结论:当前研究证据表明,在常规治疗痴呆精神行为症状的基础上,加用丙戊酸盐可明显改善痴呆患者的总体认知功能和精神行为症状,且安全性较好。因此,丙戊酸盐可作为心境稳定剂在临床合理用于痴呆精神行为症状患者。受纳入研究数量和质量的限制,上述结论尚需更多高质量研究予以验证。 OBJECTIVE To systematically review the efficacy and safety of Valproate in treatment of Behavioral and Psychological Symptoms of Dementia(BPSD).METHODS Cochrane Library,EMbase,PubMed,CNKI,CBM,VIP and WanFang data were searched for randomized controlled trials of valproate in the treatment of mental and behavioral symptoms of dementia.from inception to December 2018.Two reviewers independently screened literature,extracted data and assessed the risk of bias of included studies.Then meta-analysis was performed using RevMan 5.3 software.RESULTS A total of 14 studies involving 1043 patients were included,of which 501 patients in the experimental group and 542 patients in the control group.The results of meta-analysis showed that,compared to the control group,the valproate group could significantly increase NPI(SMD=0.46,95%CI 0.21 to 0.72,P=0.0003)and reduce MMSE(SMD=-0.36,95%CI-0.58 to-0.15,P=0.001),with significant statistical significance,without significantly increasing the risk of adverse reactions.CONCLUSION The current evidence indicates that the valproate can significantly improve the general cognitive function and mental behavior symptoms of dementia based on routine treatment with a favorable safe profile.Therefore,valproate can be used as a mood stabilizer in patients with mental and behavioral symptoms of dementia.Due to limited quantity and quality of the included studies,more large scale and high quality studies are needed to verify the above conclusion.
作者 石宇 田方圆 李海霞 秦舟 徐珽 SHI Yu;TIAN Fang-yuan;LI Hai-xia;QIN Zhou;XU Ting(Department of Clinical Pharmacy,West China Hospital,Sichuan University,Sichuan Chengdu 610041,China;West China School of Pharmacy,Sichuan University,Sichuan Chengdu 610041,China)
出处 《中国医院药学杂志》 CAS 北大核心 2019年第17期1772-1778,共7页 Chinese Journal of Hospital Pharmacy
基金 中国药学会科技开发中心项目(编号:CMEI2018KPYJ00107)
关键词 丙戊酸盐 阿尔茨海默病 痴呆精神行为症状 随机对照试验 META分析 valproate Alzheimer’s disease behavioral and psychological symptoms of dementia randomized controlled trial Meta-analysis
  • 相关文献

参考文献2

二级参考文献18

  • 1Schreiner AS,Yamamoto E,Shiotani H.Agitated behavior in elderly nursing home residents with dementia in Japan.J Gerontol B Psychol Sci Soc Sci 2000;55(3):P180-6
  • 2Lavretsky H,Sultzer D.A structured trial of risperidone for the treatment of agitation in dementia.Am J Geriatr Psychiatry 1998;6(2):127-35
  • 3Cohen-Mansfield J.Conceptualization of agitation:results based on the CohenMansfield Agitation Inventory and the Agitation Behavior Mapping Instrument.Int Psychogeriatr 1996;8 Suppl 3:309-15
  • 4Yudofsky SC,Kopecky HJ,Kunik M,et al.The Overt Agitation Severity Scale for the objective rating of agitation.J Neuropsychiatry Clin Neurosci 1997;9(4):541-8
  • 5Langa KM,Foster NL,Larson EB.Mixed dementia:emerging concepts and therapeutic implications.JAMA 2004;292(23):2901-8
  • 6Hawkins JW,Tinklenberg JR,Sheikh JI,et al.A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.A m J Geriatr Psychiatry 2000;8(3):221-5
  • 7Sannita WG.Valproate acute administration,EEG epileptic abnormalities,and ammonemia.Neurology 1992;42(10):2003-5
  • 8Stanford MS,Houston RJ,Mathias CW,et al.Characterizing aggressive behavior.Assessment 2003;10(2):183-90
  • 9范丽伟.丙戊酸镁缓释片联合盐酸多奈哌齐胶囊治疗老年痴呆精神行为障碍的疗效观察[J].内科急危重症杂志,2014,20(1):34-35. 被引量:39
  • 10梁杰,刘小北.丙戊酸钠缓释片治疗痴呆患者攻击行为的疗效与安全性评价[J].中国医院药学杂志,2014,34(10):842-844. 被引量:8

共引文献2

同被引文献26

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部